No Data
No Data
Press Release: Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to Its Board of Directors
Express News | Werewolf Therapeutics Appoints Anil Singhal, Ph.d., to Its Board of Directors
Werewolf Therapeutics Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $4
JMP Securities Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Cuts Target Price to $4
Buy Rating Affirmed for Werewolf Therapeutics Amid Strategic Advancements and Strong Financial Position